ContraFect Corporation to Present at 12th Annual BIO Investor Forum
01. Oktober 2013 09:13 ET
|
ContraFect Corporation
YONKERS, NY--(Marketwired - Oct 1, 2013) - ContraFect Corporation announced that Dr. Robert Nowinski, the company's founder and chief executive officer, and Julia P. Gregory, the company's...
ContraFect to Present at the 2013 Stifel Healthcare Conference
05. September 2013 09:13 ET
|
ContraFect Corporation
YONKERS, NY--(Marketwired - Sep 5, 2013) - ContraFect Corporation, developing biotherapeutics for life-threatening infectious diseases, today announced that Robert C. Nowinski, the Company's...
ContraFect Completes $11.8 Million Financing
04. September 2013 10:30 ET
|
ContraFect Corporation
YONKERS, NY--(Marketwired - Sep 4, 2013) - ContraFect Corporation, developing biotherapeutics for life-threatening infectious diseases, is pleased to announce that it has successfully closed a...
ContraFect Corporation Showcases CF-301 at ICAAC 2013 Meeting in Denver, CO
22. August 2013 09:57 ET
|
ContraFect Corporation
YONKERS, NY--(Marketwired - Aug 22, 2013) - ContraFect Corporation, developing biotherapeutics for life-threatening infectious diseases, is pleased to announce that ContraFect has been selected to...
ContraFect to Present at the 5th Annual Biotech Showcase
04. Januar 2013 09:13 ET
|
ContraFect Corporation
YONKERS, NY--(Marketwire - Jan 4, 2013) - ContraFect Corporation, developing biotherapeutics for life-threatening infectious diseases, today announced that Robert Nowinski, the Company's founder...
ContraFect to Present at the 11th Annual BIO Investor Forum
03. Oktober 2012 09:12 ET
|
ContraFect Corporation
YONKERS, NY--(Marketwire - Oct 3, 2012) - ContraFect Corporation, developing biotherapeutics for life-threatening infectious diseases, today announced that Julia P. Gregory, the Company's executive...
ContraFect Expands Senior Management Team
12. September 2012 09:12 ET
|
ContraFect Corporation
YONKERS, NY--(Marketwire - Sep 12, 2012) - ContraFect Corporation announced today that it has expanded the senior management of the company with the addition of biotechnology veteran Julia Gregory...
ContraFect Announces Appointment of Sir Richard Sykes to Board of Directors
26. Juni 2012 09:13 ET
|
ContraFect Corporation
YONKERS, NY--(Marketwire - Jun 26, 2012) - ContraFect Corporation announced today that Sir Richard Sykes, FRS, has joined the company's Board of Directors. Sir Richard has over 30 years of...
ContraFect Names Sol Barer Chairman of the Board
08. März 2012 09:13 ET
|
ContraFect Corporation
YONKERS, NY--(Marketwire - Mar 8, 2012) - ContraFect Corporation announced today that Sol Barer, Ph.D. has been named the company's Chairman of the Board. Dr. Barer has been a director of...
ContraFect Corporation Completes Successful Pre-IND Meeting With FDA
14. Dezember 2011 09:13 ET
|
ContraFect Corporation
YONKERS, NY--(Marketwire - Dec 14, 2011) - ContraFect Corporation, the company that is pioneering the use of recombinant proteins for the treatment of drug-resistant bacteria, completed a...